Drugs News and Research

RSS

Study finds negative health effects of anti-depressants

Commonly prescribed anti-depressants appear to be doing patients more harm than good, say researchers who have published a paper examining the impact of the medications on the entire body.

25 Apr 2012

Clinical trial to evaluate IGF-1 in children with SHANK3 deficiency

In an important test of one of the first drugs to target core symptoms of autism, researchers at Mount Sinai School of Medicine are undertaking a pilot clinical trial to evaluate insulin-like growth factor (IGF-1) in children who have SHANK3 deficiency (also known as 22q13 Deletion Syndrome or Phelan-McDermid Syndrome), a known cause of autism spectrum disorder (ASD).

25 Apr 2012

Shortage of prescription generic drugs in Canada is not a recent event: CMAJ

The shortage of prescription generic drugs in Canada is not a recent event, dating back to the fall of 2010 or earlier, states a recent history of the shortage in CMAJ.

24 Apr 2012

Chronic cocaine abuse accelerates process of brain ageing

New research by scientists at the University of Cambridge suggests that chronic cocaine abuse accelerates the process of brain ageing. The study, published today 25 April in Molecular Psychiatry, found that age-related loss of grey matter in the brain is greater in people who are dependent on cocaine than in the healthy population.

24 Apr 2012

Researchers describe novel mechanism of HIV-1 spread by dendritic cells

A new understanding of the initial interactions of human immunodeficiency virus type 1 (HIV-1) and dendritic cells is described by Boston University School of Medicine (BUSM) researchers in a study currently featured in the Proceedings of the National Academy of Sciences.

24 Apr 2012

Gabapentin drug helps people to quit cannabis

Scientists at The Scripps Research Institute have found clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, helps people to quit smoking marijuana.

24 Apr 2012

Scientists identify new way to deliver long-lasting pain relief

Scientists at the University of North Carolina at Chapel Hill have identified a new way to deliver long-lasting pain relief through an ancient medical practice.

24 Apr 2012

New report presents FDA's focus on global cooperation for product safety

The U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D. today released the agency's "Global Engagement Report," detailing the many activities and strategies FDA is using to transform from a domestic to a global public health agency. The report describes the steps the agency is taking to ensure that imported food, drugs, medical devices, and other regulated products meet the same rigorous standards for safety and quality as those manufactured domestically.

24 Apr 2012

Preventive treatments can reduce migraine attacks

Research shows that many treatments can help prevent migraine in certain people, yet few people with migraine who are candidates for these preventive treatments actually use them, according to new guidelines issued by the American Academy of Neurology.

24 Apr 2012

Viewpoints: Myths about women voters; Stopping fake drugs; Medicaid innovation not easy; The war over women

Women vote based on "women's issues," such as abortion rights and contraception. A recent poll of voters in swing states showed that women's top priorities are health care, gas prices, unemployment and the deficit -- in that order -- with "government policies toward contraception" coming in last

24 Apr 2012

Autism symptoms treatment using antidepressant SSRIs may not be effective: Review

According to a new review of published and unpublished research, the belief that certain antidepressants can help to treat repetitive behaviors in kids with autism may be based on incomplete information.

24 Apr 2012

Migraine prevention guidelines released

The latest migraine prevention guidelines will be presented at the American Academy of Neurology's annual meeting in New Orleans and published simultaneously in the journal Neurology.

24 Apr 2012

Cancer therapy with common cold virus

Common viruses have become the latest weapon against cancer. There is the case of the eight-year-old African boy diagnosed with Burkitt's lymphoma at a Ugandan health clinic. He was exposed to the measles virus and in the next few weeks his tumour regressed completely and he entered remission. But only relatively recently have scientists clinically examined the interaction between viruses and cancers in the growing area of oncolytic virotherapy.

24 Apr 2012

Study shows underutilization of epilepsy surgery

Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely adopted-in fact, it is dramatically underutilized according to a new study from the University of California, San Francisco (UCSF).

24 Apr 2012

IGF1R-blocking drugs can treat children with Wilms' tumour

An experimental drug that blocks an essential cell protein could be used to treat Wilms' tumour, a childhood cancer that affects the kidneys.

24 Apr 2012

FDA issues draft guidelines on approval process for use of nanoparticles in food and cosmetics

The United States Food and Drugs Administraton (FDA) has proposed that food companies that want to use tiny engineered particles called nanoparticles in their packaging may have to provide extra testing data to show the products are safe.

23 Apr 2012

‘Brain freeze’ provides clue to migraine cause and therapy

According to latest reports by researchers the headache that is caused by eating something cold like an ice cream, may be caused by a sudden change in brain blood flow. The U.S. team of researchers add that this study may show targets to treat other, more troubling forms of headache such as migraine.

23 Apr 2012

Aggredyne closes $3 million Series A convertible preferred stock financing

Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.

23 Apr 2012

Kenyan government must review law on counterfeit drugs, High Court rules

"Kenya's High Court ruled on Friday that lawmakers must review legislation that could threaten the import of generic drugs, allowing Kenyans to continue accessing affordable medicine," Reuters reports.

23 Apr 2012

Oligomerix to advance tau protease inhibitor program with $2M Series A financing

Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related neurodegenerative disorders, announced today the completion of approximately $2 million in Series A financing, which includes both issuance of new convertible preferred shares and debt conversion.

23 Apr 2012